CD34 and neoplasm: For this purpose, we selected HCC cases from our cohort with previously described vessels encapsulating tumor clusters (VETC)-pattern, which is known to confer unfavorable prognosis [49], and performed double-label immunohistochemistry against CD34 and E- or N-cadherin (Figure 6).